i
SUPPLEMENTARY TABLE 2. Prespecified outcomes*,† for recombinant zoster vaccine (RZV) in reports submitted to the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018
-
Published Date:
February 1, 2019
Series:MMWR. Morbidity and mortality weekly report ; v. 68, no. 4, p.Language:English
Details:
-
Description:Supplementary table for: Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018.
-
Document Type:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
- File Type:
-
Supporting Files:
application/vnd.openxmlformats-officedocument.wordprocessingml.document